Newsfeeds - Spark Newswire

3 minute read

45 Stocks Moving In Friday’s Mid-Day Session

Today, 9:02 AM

Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral.

AAOI

1 minute read

MannKind Q4 Sales $12.52M Down From $18.44M YoY

By Benzinga Newsdesk

Today, 9:02 AM

MannKind (NASDAQ:MNKD) reported $12.52 million in sales this quarter. This is a 32.14 percent decrease over sales of $18.44 million the same period last year.

MNKD

3 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 9:02 AM

CLOV

3 minute read

44 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 9:02 AM

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday.

AEZS

1 minute read

News

MannKind Corporation Granted U.S. Patent #11,241,549 ‘Dry powder inhaler and system for drug delivery’

By Charles Gross

Today, 9:02 AM

View patent here

MNKD

1 minute read

News

MannKind Corporation Granted U.S. Patent #11,185,645 ‘Dry powder inhaler and system for drug delivery’

By Charles Gross

Today, 9:02 AM

View patent here

MNKD

1 minute read

Earnings

Recap: MannKind Q3 Earnings

By Benzinga Insights

Today, 9:02 AM

MannKind (NASDAQ:MNKD) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

MNKD

6 minute read

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data

By Shanthi Rexaline

Today, 9:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ACHV

1 minute read

Mannkind Corporation Closed Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds

By Charles Gross

Today, 9:02 AM

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced the closing on November 8, 2021, of its previously announced sale-leaseback transaction with an affiliate of Creative Manufacturing Prop

MNKD

1 minute read

Mannkind Corporation Closed Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds

By Charles Gross

Today, 9:02 AM

MNKD